On the use of biomarkers for environmental health research

Statistical Methods in Medical Research

Volumn 13, Issue 3, 2004, Pages 207-225

  Ryan, Louise ^a   Huang, Wenzheng ^b   Thurston, Sally W ^c   Kelsey, Karl T ^d   Wiencke, John K ^e   Christiani, David C ^d  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b Millennium Operations   (United States)

^c UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; DNA;

ANALYSIS OF VARIANCE; ARTICLE; CALCULATION; CASE CONTROL STUDY; CIGARETTE SMOKING; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA ADDUCT; DOSE RESPONSE; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL HEALTH; HUMAN; LUNG CANCER; MICRONUCLEUS; NORMAL DISTRIBUTION; OUTCOMES RESEARCH; PREDICTION; QUANTITATIVE ANALYSIS; RISK ASSESSMENT; SISTER CHROMATID EXCHANGE;

EID: 2542600711     PISSN: 09622802     EISSN: None     Source Type: Journal    
DOI: 10.1191/0962280204sm364ra     Document Type: Article

References (40)

1. Ward JB, Henderson RE. Identification of needs in biomarker research. Environmental Health Perspectives 1996; 104: 895-900.
2. Christiani D. Utilization of biomarker data for clinical and environmental intervention. Environmental Health Perspectives 1996; 104: 921-26.
3. Schulte PA. A conceptual and historical framework for molecular epidemiology. In Schulte PA, Perera FP, eds. Molecular Epidemiology Principles and Practices. New York: Academic Press, 1993.
4. Garcia-Closas M, Kelsey KT, Wiencke JK, Xu X, Wain JC, Christiani DC. A case-control study of cytochrome P450 1A1 glutathione S-transferase M1 cigarette smoking and lung cancer susceptibility. Cancer Causes and Control 1997; 8: 544-53.
5. Schut HAJ, Shiverick KT. DNA adducts in humans as dosimeters of exposure to environmental occupational or dietary genotoxins. Federation of American Society of Experimental Biology 1992; Bethesda 2942-2951.
6. Perera FP, Santella RM. Carcinogenesis. In: Schulte P, Perera F, eds. Molecular Epidemiology Principles and Practices. New York: Academic Press, 1993.
7. Cheng T-J, Christiani DC, Xu X, Wain JC, Wiencke JK, Kelsey KT. Increased micronucleus frequency in lymphocytes from smokers with lung cancer. Mutation Research 1996; 349: 43-50.
8. Sram RJ, Binkova J. Molecular epidemiology studies on occupational and environmental exposure to mutagens and carcinogens 1997-1999. Environmental Health Perspectives Suppl. 1 2000; 108: 57-70.
9. Kelsey KT, Wiencke JK, Eisen EA, Lynch DW, Lewis TR, Little JB. Persistently elevated sister chromatic exchanges in thylene oxide-exposed primates: the role of a subpopulation of higher frequency cells. Cancer Research 1988; 48: 5045-50.
10. Cheng T-J, Christiani DC, Xu X, Wain JC, Wiencke JK, Kelsey KT. Glutathione S-transferase μ-genotype diet and smoking as determinants of sister chromatid exchange frequency in lymphocytes. Cancer Epidemiology Biomarkers and Prevention 1995a; 4: 535-42.
11. Cheng T-J, Christiani DC, Wiencke JK, Wain JC, Xu X, Kelsey KT. Comparison of sister chromatid exchange frequency in peripheral lymphocytes in lung cancer cases and controls. Mutation Research 1995b; 348: 75-82.
12. Duell EJ, Wiencke JK, Cheng T-J, Varkonyi A, Zuo Z, Ashok TDS, Mark EJ, Wain JC, Christiani DC, Kelsey KT. Polymorphisms in the DNA repair genes XRCC1 and ERCC2 and biomarkers of DNA damage in human blood mononuclear cells. Carcinogenesis 2000; 21: 956-71.
13. Little RJA, Rubin DB. Statistical analysis with missing data. New York: Wiley, 1987.
14. Lawless JF, Kalbfleisch JD. Semiparametric methods for response-selective and missing data problem in regression. Journal of the Royal Statistical Society B 1999; 61: 413-38.
15. Kalbfleisch JD, Lawless JF. Likehood analysis of multi-state models for disease incidence and mortality. Statistics in Medicine 1988; 7: 149-60.
16. Whittemore AS. Multistate sampling designs and estimating equations. Journal of the Royal Statistical Society B 1997; 59: 589-602.
17. Breslow NE, Cain KC. Logistic regression for two-stage case-control data. Biometrika 1988; 75: 11-20.
18. Wild CJ. Fitting prospective regression models to case-control data. Biometrika 1991; 78: 705-17.
19. Robins JM, Rotnitzky A, Zhao LP, Lipsitz S. Estimation of regression coefficients when some regressors are not always observed. Journal of the American Statistical Association 1994; 89: 846-66.
20. Reilly M, Pepe MS. The relationship between hot-deck multiple imputation and weighted likelihood. Statistics in Medicine 1997; 16: 5-19.
21. Reilly M, Pepe MS. A mean score method for missing and auxiliary covariate data in regression models. Biometrika 1995; 82: 299-314.
22. Ibrahim JG. Incomplete data in generalized linear models. Journal of the American Statistical Association 1990; 85: 765-69.
23. Lipsitz SR, Ibrahim JG. A conditional model for incomplete covariates in parametric regression models. Biometrika 1996; 83: 916-22.
24. Horton NJ, Laird NM. Maximum likelihood analysis of logistic regression models with incomplete covariate data auxiliary information. Biometrics 2001; 57: 34-42.
25. Satten GA, Carroll RJ. Conditional and unconditional categorical regression models with missing covariates. Biometrics 2000; 56: 384-88.
26. Prentice RL. Surrogate endpoints in clinical trials: definitions and operational criteria. Statistics in Medicine 1989; 8: 431-40.
27. Fleming TR, Prentice RL, Pepe MS, Glidden D. Surrogate and auxiliary endpoints in clinical trials with potential applications in cancer and AIDS research. Statistics in Medicine 1994; 13: 955-68.
28. Buyse M, Molenberghs G. Criteria for the validation of surrogate endpoints in randomized experiments. Biometrics 1998; 54: 1014-29.
29. Zhao LP, Lipsitz S. Design and analysis of two-stage studies. Statistics in Medicine 1992; 11: 769-82.
30. Carroll RJ, Ruppert D, Stefanski LA. Measurement error in nonlinear models. London: Chapman and Hall, 1995.
31. Xu X, Kelsey KT, Wiencke JK, Wainn JC, Christiani DC. Cytochtome P450 CYP1A1 MspI polymorphism and lung cancer susceptibility. Cancer Epidemiology Biomarkers and Prevention 1996; 5: 687-92.
32. Liu G, Miller DP, Zhou W, Thurston SW, Fan R, Xu LL, Lynch TJ, Wain JC, Su L, Christiani DC. Differential association of the codon 75 p53 and GSTM1 polymorphisms on histologic type of non-small cell lung carcinoma. Cancer Research 2001; 61: 8718-22.
33. Zhou W, Liu G, Thurston SW, Xu LL, Miller DP, Wain JC, Lynch TJ, Su L, Christiani DC. Genetic polymorphisms of N-acetyltranferase-2 and microsomal epoxide hydrolase and cumulative cigarette smoking in lung cancer. Cancer Epidemiology Biomarkers and Prevention 2002; 11: 15-21.
34. Zhou W, Liu G, Miller DP, Thurston SW, Xu LL, Wain JC, Lynch TJ, Su L, Christiani DC. Gene-environment interaction for the ERCC2 polymorphisms and cumulative cigarette smoking exposure in lung cancer. Cancer Research 2002; 62: 1377-81.
35. Riccardo P, Fabrizia T, Li Z, Stefano B. Mathematical modeling in risk/exposure assessment of tobacco related lung cancer. Carcinogenesis 1995; 16: 1465-71.
36. Spivack SD, Fasco MJ, Walker VE, Kaminsky LS. The molecular epidemiology of lung cancer. Critical Reviews in Toxicology 1997; 27: 319-65.
37. Griewank A, Corliss GF. Automatic Differentiation of Algorithm: Theorem Implementation and Application SIAM Proceeding Series List Philadelphia, 1991.
38. Huang WZ, Zeger SL, Anthony JC, Garrett EA. Latent variable model for joint analysis of multiple repeated measures and bivariate event times. Journal of the American Statistical Association 2001; 96: 906-14.
39. Shannon CE, Weaver W. The Mathematical Theory of Communication. Champaign IL: University of Illinois Press, 1959.
40. Soofi ES. Capturing the intangible concept of information. Journal of the American Statistical Association 1994; 89: 1243-54.